Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins

Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins

Source: 
Drugs.com
snippet: 

A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina. This Phase 1 trial will test the experimental vaccine, known as H1ssF-3928 mRNA-LNP, for safety and its ability to induce an immune response.